HIMS

Hims & Hers Health Inc

29.21

Oct 20 • 3:59 PM ET +1.06 (3.77%)

29.38

Aftermarket • 7:59 PM ET +0.17 (0.58%)

Healthcare Drug Manufacturers - Specialty & Generic USA Mid NYSE

Today, 1:20 PMHims & Hers launches online men’s weight-management offering in Germany, marking its entry into the German market and expanding in Europe

Peers: LFMD TDOC GDRX WW NVO DOCS OSCR AMWL LLY PHR

| Held by: IJH VTI IWM VB VBK VXF IWO MDY VTWO IJK

Scroll to Statements

Index	RUT
Market Cap	6.82B
Enterprise Value	7.52B
Income	-142.03M
Sales	2.58B
Book/sh	1.39
Cash/sh	3.60
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2442
IPO	Sep 13, 2019

P/E	-
Forward P/E	97.91
PEG	9.15
P/S	2.64
P/B	21.03
P/C	8.10
P/FCF	105.38
EV/EBITDA	86.99
EV/Sales	2.92
Quick Ratio	0.87
Current Ratio	0.93
Debt/Eq	4.77
LT Debt/Eq	4.74
Option/Short	Yes / Yes

EPS (ttm)	-0.62
EPS next Y	0.30
EPS next Q	0.06
EPS this Y	-215.55%
EPS next Y	150.62%
EPS next 5Y	10.70%
EPS past 3/5Y	- -
Sales past 3/5Y	64.55% 73.63%
EPS Y/Y TTM	-169.91%
Sales Y/Y TTM	28.04%
EPS Q/Q	-320.75%
Sales Q/Q	38.25%
Earnings	Nov 09 AMC
EPS/Sales Surpr.	-642.97% 7.77%

Insider Own	9.19%
Insider Trans	-1.60%
Inst Own	66.96%
Inst Trans	1.77%
ROA	-5.16%
ROE	-32.03%
ROIC	-7.64%
Gross Margin	54.19%
Oper. Margin	-0.03%
Profit Margin	-5.51%
SMA20	0.17%
SMA50	0.03%
SMA200	7.29%
Trades

Shs Outstand	224.92M
Shs Float	211.88M
Short Float	25.85%
Short Ratio	4.55
Short Interest	54.77M
52W High	52.41 -44.27%
52W Low	13.74 112.59%
Volatility	8.55% 6.77%
ATR (14)	1.93
RSI (14)	50.39
Beta	2.52
Rel Volume	0.88
Avg Volume	12.05M
Volume	10,550,812

Perf Week	-1.68%
Perf Month	-0.48%
Perf Quarter	-7.80%
Perf Half Y	-1.85%
Perf YTD	-10.04%
Perf Year	-43.13%
Perf 3Y	386.83%
Perf 5Y	251.93%
Perf 10Y	-
Recom	2.53
Target Price	32.15
Prev Close	28.15
Price	29.21
Change %	3.77%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-11-26	Resumed	JP Morgan	Neutral	$32
May-12-26	Reiterated	Needham	Buy	$30 → $35
Apr-24-26	Initiated	JP Morgan	Overweight	$35
Mar-10-26	Upgrade	Citigroup	Sell → Neutral	$24
Mar-10-26	Upgrade	BofA Securities	Underperform → Neutral	$23
Mar-09-26	Upgrade	Needham	Hold → Buy	$30
Feb-24-26	Downgrade	BTIG Research	Buy → Neutral
Jan-12-26	Initiated	Evercore ISI	In-line	$33
Dec-09-25	Initiated	Barclays	Overweight	$48
Oct-21-25	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line

Show Previous Ratings

Today 01:10PM	HIMS Stock Gains As Company Enters German Mens Weight Market As Investors Watch US Peptide Compounding Policy (Stocktwits)
Oct-15-26 10:04PM	HIMS Stock Snaps 3-Day Slump On Peptide Hopes: Trump Administration Reviews Plan That Could Unlock $2.2B Market (Stocktwits) +5.99%
Oct-14-26 08:58AM	Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately (PR Newswire) -6.70%
Oct-13-26 11:21AM	3 Stocks Seeing Notable Price Action Today: BMBL, CIFR, HIMS (Schaeffer's Research)
Oct-12-26 06:53PM	Should You Trim Or Add To Your Hims & Hers Position Now? (Trefis)
04:05PM	Loading…
04:05PM	Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026 (Business Wire)
Oct-11-26 11:04AM	Hims & Hers Stock Jumped 10% in a Day as Volume Hit 15.9 Million Shares. Heres Where the Stock Could Go by 2030 (TIKR)
Oct-08-26 05:39PM	Is Hims & Hers Stock Ready For A Longer Cash Burn? (Trefis) -5.01% +10.19%
03:30PM	Kaplan Fox & Kilsheimer LLP Encourages Hims & Hers Health, Inc. (HIMS) Investors With Losses to Seek Appointment as Lead Plaintiff Before November 2, 2026 (Newsfile)
Oct-07-26 04:17PM	Hims & Hers Names Jon Franklin as Chief Accounting Officer (Business Wire)
Oct-02-26 11:13AM	Robinhoods Tokenized Stocks Are Becoming a New Memecoin Trade: Report (CryptoProwl)
Oct-01-26 06:00AM	Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership (Business Wire)
Sep-30-26 04:00PM	Kaplan Fox Urges Investors of Hims & Hers Health, Inc. (HIMS) to Seek a Leadership Role Before November 2, 2026 (Newsfile)
Sep-29-26 03:45PM	Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors Seeking Recovery to Contact the Firm Before November 2, 2026 (Newsfile)
Sep-28-26 04:26PM	Hims & Hers Stock: 30% Growth Cant Hide a Margin Problem (TIKR)
08:39AM	Loading…
Sep-23-26 08:39AM	FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow. (MarketWatch) -6.70%
Sep-22-26 02:28PM	Hims & Hers Just Went Negative on Profit. Twice. (TIKR)
Sep-15-26 03:08PM	Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately (PR Newswire)
Sep-14-26 03:21PM	HIMS Bulls Should Heed This Historic Chart Signal (Schaeffer's Research)
01:30PM	Robbins LLP is Investigating Allegations that Hims & Hers Health, Inc. Shared Customers' Protected Information With Advertising Platforms and Engaged in Other Deceptive Advertising Practices (Newsfile)
Sep-11-26 05:12PM	JPMorgan Tweaks Hims & Hers Stock Outlook on Key Risk (GuruFocus.com)
09:14AM	JPMorgan cautious on Hims & Hers on GLP-1 transition risk (Investing.com)
Sep-10-26 02:19PM	Pump.fun Launches Custom Pairs for Tokenized Stocks (Bankless)
Sep-04-26 03:16PM	Crypto Traders Are Pairing Meme Coins With Stocks on RobinhoodAnd It's Working (Sort Of) (decrypt)
Sep-03-26 04:00PM	Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors with Significant Losses to Contact the Firm Before November 2, 2026 (Newsfile)
10:39AM	Hims & Hers Health, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights HIMS (Business Wire)
Sep-02-26 09:30AM	Kaplan Fox Urges Hims & Hers Health, Inc. (HIMS) Investors to Contact the Firm About Possible Securities Law Violations (Newsfile)
12:36AM	HIMS Stock Kicks Off September In The Red: FDAs GLP-1 Alert Steals The Spotlight From Australia Expansion (Stocktwits)
Sep-01-26 02:30PM	Hims & Hers falls after FDA crackdown on unapproved weight-loss drugs (Proactive)
07:41AM	Nasdaq tumbles as rising yields fuel market selloff (Proactive)
03:29PM	Loading…
Aug-31-26 03:29PM	Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest (Trefis)
03:00PM	Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market (Business Wire)
11:45AM	Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) to Contact the Firm to Learn About Their Legal Rights (Newsfile)
Aug-28-26 11:30AM	Kaplan Fox is Investigating Hims & Hers Health, Inc. (HIMS) for Potential Violations of the Federal Securities Laws (Newsfile) -8.91%
Aug-26-26 10:45AM	Kaplan Fox & Kilsheimer LLP is Investigating Hims & Hers Health, Inc. (HIMS) for Possible Securities Law Violations (Newsfile) -6.05%
Aug-25-26 06:23PM	How GLP-1 Sales Could Play Out for Hims & Hers (Barrons.com)
08:17AM	Hims & Hers Shares Tumble on Visa Dispute Crackdown (GuruFocus.com)
Aug-24-26 11:55PM	HIMS Stock Posts Worst Day In A Month As Visa Flags Disputes But Analyst Says GLP-1 Users Are Sticking Around (Stocktwits) -7.99%
Aug-20-26 03:21PM	Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash (Trefis)
Aug-19-26 02:45PM	Kaplan Fox is Investigating Hims & Hers Health, Inc. (HIMS) on Behalf of Investors for Potential Securities Law Violations (Newsfile) +13.51%
Aug-18-26 07:55PM	Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm (PR Newswire)
01:16PM	Hims & Hers CEO Andrew Dudum pushes back on FTC lawsuit (Quartz)
12:12PM	Hims & Hers CEO Andrew Dudum Says AI Health Coach Could Be Just 12 Months Away, Believes It Could Increase Medication Adherence (Stocktwits)
11:32AM	Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors" (Investing.com)
10:29AM	Hims & Hers CEO Tells the FTC That Regulators Just Dont Understand (Moby)
Aug-17-26 11:22PM	HIMS Stock Has Quadrupled In 5 Years: How Hims Turned A $3 Stock Into A Telehealth Giant (Stocktwits)
01:15PM	Kaplan Fox is Investigating Hims & Hers Health, Inc. (HIMS) and Encourages Investors Who Suffered Losses to Contact the Firm (Newsfile)
08:55AM	Uniphore Launches Marketing AI to Usher in New Era: NYSE Content Update (PR Newswire)
Aug-16-26 10:57PM	HIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug Marketplace (Stocktwits)
Aug-12-26 09:07AM	Eli Lilly is suing pharmacies and peptide vendors over premature sales of the next big weight-loss drug: retatrutide (MarketWatch)
Aug-11-26 09:33PM	HIMS Stock Snaps 2-Day Climb: Analyst Says Record Subscriber Growth Not Enough To Offset Margin Slide (Stocktwits)
11:35AM	Hims & Hers Q2 revenue beat offset by wider-than-expected loss (Proactive)
11:26AM	Citi Says Hims & Hers Full-Year Outlook Indicates Hefty Q4 Earnings Lift, Warns Of Execution Risks (Stocktwits)
10:17AM	Hims & Hers Health Slides on Wider-Than-Expected Q2 Loss (Schaeffer's Research)
08:49AM	Hims & Hers' Revenue Growth Comes at a Cost (GuruFocus.com)
08:33AM	Hims & Hers Raises Outlook as Cash Flow Weakens (GuruFocus.com)
07:23AM	Hims & Hers Q2 2026 earnings: loss despite revenue beat (Quartz)
07:21AM	Hims & Hers shares slide as costly weight-loss push squeezes margins (Reuters)
06:56AM	AST SpaceMobile, Intel, On, Hims, and More Stocks That Explain Today's Market (Barrons.com)
01:01AM	Hims & Hers Health Inc (HIMS) (Q2 2026) Earnings Call Highlights: Revenue Surges 40% to ... (GuruFocus.com)
Aug-10-26 10:04PM	HIMS Retail Traders Flip Bullish After Q2 Print: Hims & Hers Keeps $225M Buyback Ready For Stock Disconnect (Stocktwits)
07:37PM	HIMS Falls 6% After Hours On Q2 Loss Eyes Oral Testosterone And Peptides Expansion (Stocktwits)
05:58PM	Hims Stock Falls on Earnings. Why a Guidance Hike Isn't Enough. (Barrons.com)
05:27PM	Hims & Hers Lowers Profit Forecast, Shares Drop (Bloomberg)
04:50PM	Hims Topples As Obesity Kingpin Hits A Snag On Weighty Second-Quarter Loss (Investor's Business Daily)
04:44PM	Hims & Hers shares fall after second-quarter wider-than-expected loss (Investing.com)
04:41PM	Hims & Hers Health Boosts Revenue Target, Swings to Second-Quarter Loss (The Wall Street Journal)
10:37AM	Trading Week Awaits Inflation Reports Starting Wednesday (Zacks)
10:15AM	Kaplan Fox & Kilsheimer LLP Encourages Hims & Hers Health, Inc. (HIMS) Investors to Contact the Firm Regarding Potential Securities Law Violations (Newsfile)
Aug-06-26 03:29PM	Inflation Data, Tech Earnings Highlight Busy Week (Schaeffer's Research) -6.29%
Jul-31-26 01:00AM	Here Comes the Next Wave of GLP-1s. They'll Treat a Lot More Than Obesity. (Barrons.com)
Jul-30-26 09:26PM	HIMS Stock Eyes 4-Week Losing Streak: Legal Woes Fuel Very High Uncertainty As Analyst Sticks To No Moat Call (Stocktwits) +8.16%
05:38PM	Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy? (Trefis)
Jul-29-26 05:20PM	FTC sues Hims & Hers, alleging it shared health data with Meta, Snap (CBS News) -14.73%
02:50PM	FTC sues Hims & Hers over health data sharing, billing (Quartz)
02:41PM	FTC Sues Hims & Hers, Alleging Unlawful Sharing of Data, Deceptive Billing (The Wall Street Journal)
02:27PM	Why Is HIMS Stock Down 13% Today? (Stocktwits)
01:51PM	Hims & Hers Responds to FTC Lawsuit (Business Wire)
01:34PM	Hims & Hers Stock Plunges After FTC Sues Over Alleged Privacy Violations (Barrons.com)
12:38PM	Exclusive-US FTC suing Hims & Hers for sending user health info to Meta, Snap (Reuters)
12:34PM	US FTC sues Hims & Hers for sending user health info to Meta, Snap (Reuters)
Jul-28-26 09:33PM	HIMS Stock Eyes Comeback After 3-Week Slide: BlackRock Raises Stake, Bulls Bet On Peptide-Fueled Q2 Run (Stocktwits)
Jul-27-26 12:52AM	HIMS Stock Rises Overnight: Retail Traders Bet On Peptides Upside After FDA Panel Backs 6 Of 7 Compounds (Stocktwits) +7.65%
Jul-25-26 09:32AM	A Hims cofounder fired his marketing agency for an AI-powered team. Now his 24/7 online vet service is growing 20% a month (Fortune)
Jul-23-26 11:40PM	HIMS Stock Climbs Overnight As FDA Advisory Panel Backs 4 Peptides Pharma Bro Martin Shkreli Goes Short (Stocktwits) -14.20%
04:31PM	What the FDA's Peptide Decision Means for Hims & Hers' Long-Term Telehealth Strategy (Barrons.com)
02:32PM	Hims, The Surprise Winner Of The FDA Showdown With Peptides, Bounds Higher (Investor's Business Daily)
02:15PM	Why Is HIMS Stock Rallying 13% Today? (Stocktwits)
10:10AM	Quest Diagnostics Surges After Hims- And Oura-Tied Beat (Investor's Business Daily)
09:18AM	The FDA is about to decide which peptides could soon become widely available in the U.S. Here's what happens next. (MarketWatch)
Jul-22-26 01:41AM	HIMS Stock Snaps 3-Day Losing Streak: FDA Adds 8 New Peptide Voters Deemed More Qualified And Less Conflicted (Stocktwits)
Jul-21-26 09:34AM	Popular Drug Maker Slams GLP-1 Peer on False Advertising (Schaeffer's Research)
02:43AM	HIMS Stock On A 3-Day Slide: CFO Cashes Out $229K In Shares Ahead Of FDA Peptide Meeting (Stocktwits)
Jul-17-26 04:17PM	Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company (Business Wire)
Jul-16-26 12:15PM	This Trade Offers Two Ways To Profit From Hims & Hers Stock (Investor's Business Daily) -9.39%
Jul-13-26 04:05PM	Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026 (Business Wire)
03:23AM	HIMS Stock Logs Worst Week In 2 Months Turns To Peptides Campaign Ahead Of Key FDA Meeting (Stocktwits)
Jul-05-26 11:29PM	HIMS Stock Rises Overnight: CEO Shrugs Off Wild Swings, Bets On Gold Standard Of Healthcare Over Next Decade (Stocktwits)
02:00AM	Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In? (Barrons.com)
Jul-01-26 09:41PM	HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan Retail Gets Less Bearish (Stocktwits) +8.36%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Boughton Soleil	Chief Legal Officer	Oct 14 '26	Sale	29.06	3,461	100,577	297,348	Oct 15 04:44 PM
Boughton Soleil	Officer	Oct 14 '26	Proposed Sale	29.06	3,461	100,577		Oct 14 09:44 AM
Okupe Oluyemi	Chief Financial Officer	Oct 01 '26	Sale	29.70	2,000	59,400	234,527	Oct 02 04:32 PM
Boughton Soleil	Chief Legal Officer	Sep 30 '26	Sale	29.17	3,461	100,957	300,809	Oct 02 04:31 PM
Okupe Oluyemi	Officer	Oct 01 '26	Proposed Sale	29.70	2,000	59,400		Oct 01 12:05 PM
Boughton Soleil	Officer	Sep 30 '26	Proposed Sale	29.17	3,461	100,957		Sep 30 10:31 AM
Okupe Oluyemi	Chief Financial Officer	Sep 22 '26	Option Exercise	5.01	14,000	70,140	265,804	Sep 23 04:17 PM
Okupe Oluyemi	Chief Financial Officer	Sep 22 '26	Sale	29.95	29,277	876,846	236,527	Sep 23 04:17 PM
Okupe Oluyemi	Officer	Sep 22 '26	Proposed Sale	29.95	29,277	876,846		Sep 22 12:12 PM
Okupe Oluyemi	Chief Financial Officer	Sep 17 '26	Sale	28.82	12,313	354,861	251,804	Sep 18 04:17 PM
Boughton Soleil	Chief Legal Officer	Sep 16 '26	Sale	27.86	6,236	173,735	304,270	Sep 17 04:17 PM
Chi Michael	Chief Operating Officer	Sep 15 '26	Sale	28.39	14,027	398,227	456,660	Sep 17 04:17 PM
Elshenawy Mohamed	CTO	Sep 15 '26	Sale	28.39	7,954	225,814	185,556	Sep 17 04:17 PM
Okupe Oluyemi	Officer	Sep 17 '26	Proposed Sale	28.82	12,313	354,861		Sep 17 03:55 PM
Boughton Soleil	Officer	Sep 16 '26	Proposed Sale	27.86	6,236	173,735		Sep 16 10:05 AM
Elshenawy Mohamed	Officer	Sep 15 '26	Proposed Sale	28.39	7,954	225,814		Sep 15 10:22 AM
Chi Michael	Officer	Sep 15 '26	Proposed Sale	28.39	14,027	398,227		Sep 15 10:14 AM
Boughton Soleil	Chief Legal Officer	Sep 02 '26	Sale	28.33	3,458	97,965	310,506	Sep 03 04:31 PM
Boughton Soleil	Officer	Sep 02 '26	Proposed Sale	28.33	3,458	97,965		Sep 02 12:24 PM
Autor Deborah M.	Chief Policy Officer	Aug 18 '26	Sale	27.85	16,773	467,128	48,961	Aug 20 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Aug 19 '26	Option Exercise	5.01	4,938	24,739	269,055	Aug 20 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Aug 19 '26	Sale	29.99	4,938	148,111	264,117	Aug 20 04:30 PM
Boughton Soleil	Chief Legal Officer	Aug 19 '26	Sale	27.55	25,111	691,808	313,964	Aug 20 04:30 PM
Boughton Soleil	Officer	Aug 19 '26	Proposed Sale	27.55	25,111	691,808		Aug 19 09:41 AM
Okupe Oluyemi	Chief Financial Officer	Aug 17 '26	Option Exercise	5.01	9,388	47,034	273,505	Aug 18 05:04 PM
Okupe Oluyemi	Chief Financial Officer	Jun 18 '26	Sale	35.09	55,383	1,943,389	228,938	Aug 18 05:04 PM
Okupe Oluyemi	Chief Financial Officer	Aug 17 '26	Sale	27.89	9,388	261,802	264,117	Aug 18 05:04 PM
Autor Deborah M.	Officer	Aug 18 '26	Proposed Sale	27.85	16,773	467,128		Aug 18 10:37 AM
Pendarvis Christiane	Former Director	Jul 22 '26	Proposed Sale	32.37	3,500	113,278		Jul 22 11:12 AM
Okupe Oluyemi	Chief Financial Officer	Jul 17 '26	Option Exercise	5.01	7,163	35,887	291,484	Jul 20 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Jul 17 '26	Sale	31.99	7,163	229,168	284,321	Jul 20 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Jul 06 '26	Option Exercise	5.01	7,163	35,887	291,484	Jul 07 04:20 PM
Okupe Oluyemi	Chief Financial Officer	Jul 06 '26	Sale	36.49	7,163	261,351	284,321	Jul 07 04:20 PM
Oluyemi Okupe	Officer	Jul 06 '26	Proposed Sale	38.28	28,652	1,096,799		Jul 06 06:17 PM
Carroll Patrick Harrison	Chief Medical Officer	Jun 18 '26	Sale	35.00	23,726	830,410	181,861	Jun 23 06:39 PM
Okupe Oluyemi	Chief Financial Officer	Jun 22 '26	Option Exercise	5.01	6,376	31,944	302,518	Jun 23 06:39 PM
Okupe Oluyemi	Chief Financial Officer	Jun 22 '26	Sale	34.03	18,197	619,217	284,321	Jun 23 06:39 PM
Carroll Patrick Harrison	Officer	Jun 18 '26	Proposed Sale	35.00	23,726	830,410		Jun 18 03:02 PM
Chi Michael	Chief Operating Officer	Jun 17 '26	Sale	31.50	14,027	441,850	432,124	Jun 17 06:50 PM
Becklund Irene	PAO	Jun 16 '26	Sale	30.25	7,573	229,083	11,280	Jun 17 06:50 PM
Becklund Irene	PAO	Jun 17 '26	Sale	31.50	4,490	141,435	6,790	Jun 17 06:50 PM
Elshenawy Mohamed	CTO	Jun 17 '26	Sale	31.50	30,040	946,260	101,023	Jun 17 06:50 PM
Becklund Irene	Officer	Jun 17 '26	Proposed Sale	31.50	4,490	141,435		Jun 17 11:17 AM
Elshenawy Mohamed	Officer	Jun 17 '26	Proposed Sale	31.50	30,040	946,260		Jun 17 11:10 AM
Chi Michael	Officer	Jun 17 '26	Proposed Sale	31.50	14,027	441,850		Jun 17 09:47 AM
Becklund Irene	Officer	Jun 16 '26	Proposed Sale	30.25	7,573	229,083		Jun 16 11:21 AM
WELLS DAVID B	Director	May 26 '26	Buy	24.23	48,400	1,172,974	224,417	May 26 04:48 PM
Okupe Oluyemi	Chief Financial Officer	May 18 '26	Option Exercise	5.01	7,950	39,830	270,904	May 19 07:39 PM
Okupe Oluyemi	Chief Financial Officer	May 18 '26	Sale	23.64	7,950	187,916	262,954	May 19 07:39 PM
Boughton Soleil	Chief Legal Officer	Apr 20 '26	Sale	30.00	9,463	283,890	299,368	Apr 22 05:24 PM
Okupe Oluyemi	Chief Financial Officer	Apr 20 '26	Option Exercise	8.65	12,553	108,531	282,599	Apr 22 05:24 PM
Okupe Oluyemi	Chief Financial Officer	Apr 20 '26	Sale	29.96	19,645	588,615	262,954	Apr 22 05:24 PM
Okupe Oluyemi	Chief Financial Officer	Apr 17 '26	Option Exercise	5.01	6,184	30,982	288,051	Apr 20 04:38 PM
Okupe Oluyemi	Chief Financial Officer	Apr 16 '26	Sale	25.90	36,922	956,147	281,867	Apr 20 04:38 PM
Okupe Oluyemi	Chief Financial Officer	Apr 17 '26	Sale	27.83	18,005	501,158	270,046	Apr 20 04:38 PM
Boughton Soleil	Officer	Apr 20 '26	Proposed Sale	30.00	9,463	283,890		Apr 20 01:19 PM
Okupe Oluyemi	Chief Financial Officer	Apr 06 '26	Option Exercise	5.01	3,975	19,915	322,764	Apr 07 05:14 PM
Okupe Oluyemi	Chief Financial Officer	Apr 06 '26	Sale	19.98	3,975	79,409	318,789	Apr 07 05:14 PM
Oluyemi Okupe	Officer	Apr 06 '26	Proposed Sale	20.33	240,560	4,890,585		Apr 06 06:03 PM
Okupe Oluyemi	Chief Financial Officer	Mar 20 '26	Option Exercise	5.01	4,489	22,490	328,006	Mar 24 06:09 PM
Okupe Oluyemi	Chief Financial Officer	Mar 20 '26	Sale	23.77	9,217	219,067	318,789	Mar 24 06:09 PM
Becklund Irene	PAO	Mar 17 '26	Sale	24.69	5,529	136,511	8,752	Mar 18 04:17 PM
Boughton Soleil	Chief Legal Officer	Mar 17 '26	Sale	24.69	4,812	118,808	308,831	Mar 18 04:17 PM
Chi Michael	Chief Operating Officer	Mar 17 '26	Sale	24.69	97,289	2,402,065	407,282	Mar 18 04:17 PM
Boughton Soleil	Officer	Mar 17 '26	Proposed Sale	24.69	4,812	118,808		Mar 17 12:41 PM
Becklund Irene	Officer	Mar 17 '26	Proposed Sale	24.69	5,529	136,511		Mar 17 11:39 AM
Chi Michael	Officer	Mar 17 '26	Proposed Sale	24.69	97,289	2,402,065		Mar 17 10:06 AM
Boughton Soleil	Chief Legal Officer	Feb 27 '26	Sale	15.21	4,651	70,742	440,972	Mar 02 04:18 PM
Boughton Soleil	Officer	Feb 27 '26	Proposed Sale	15.21	4,651	70,742		Feb 27 10:09 AM
Okupe Oluyemi	Chief Financial Officer	Feb 03 '26	Option Exercise	5.01	5,262	26,363	96,879	Feb 04 04:13 PM
Okupe Oluyemi	Chief Financial Officer	Feb 03 '26	Sale	26.44	5,262	139,108	91,617	Feb 04 04:13 PM
Okupe Oluyemi	Chief Financial Officer	Jan 20 '26	Option Exercise	6.27	9,067	56,836	100,684	Jan 21 04:23 PM
Okupe Oluyemi	Chief Financial Officer	Jan 20 '26	Sale	30.34	9,067	275,114	91,617	Jan 21 04:23 PM
Oluyemi Okupe	Officer	Jan 20 '26	Proposed Sale	30.47	27,204	828,906		Jan 20 04:34 PM
Okupe Oluyemi	Chief Financial Officer	Jan 05 '26	Option Exercise	9.16	5,986	54,818	100,687	Jan 07 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Jan 05 '26	Sale	33.79	9,070	306,453	91,617	Jan 07 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Dec 22 '25	Sale	35.72	23,090	824,710	94,333	Dec 23 04:15 PM
Oluyemi Okupe	Officer	Dec 22 '25	Proposed Sale	35.05	32,160	1,127,208		Dec 22 05:00 PM
Chi Michael	Chief Operating Officer	Dec 17 '25	Sale	36.71	13,750	504,762	305,161	Dec 18 04:15 PM
Autor Deborah M.	Chief Policy Officer	Dec 17 '25	Sale	36.71	7,054	258,952	6,175	Dec 18 04:15 PM
Carroll Patrick Harrison	Chief Medical Officer	Dec 17 '25	Sale	36.71	10,021	367,871	169,940	Dec 18 04:15 PM
Becklund Irene	PAO	Dec 17 '25	Sale	36.71	8,411	308,768	2,126	Dec 18 04:15 PM
Carroll Patrick Harrison	Officer	Dec 17 '25	Proposed Sale	36.71	10,021	367,871		Dec 17 10:26 AM
Chi Michael	Officer	Dec 17 '25	Proposed Sale	36.71	13,750	504,762		Dec 17 10:14 AM
Becklund Irene	Officer	Dec 17 '25	Proposed Sale	36.71	8,411	308,768		Dec 17 09:50 AM
Autor Deborah M.	Officer	Dec 17 '25	Proposed Sale	36.71	7,054	258,952		Dec 17 09:42 AM
Perez Garcia Andrea G	Director	Dec 09 '25	Sale	39.17	2,500	97,925	80,166	Dec 10 04:35 PM
Perez Garcia Andrea G	Director	Dec 09 '25	Proposed Sale	39.17	2,500	97,925		Dec 09 10:07 AM
Boughton Soleil	Chief Legal Officer	Nov 24 '25	Sale	35.22	2,631	92,664	153,225	Nov 25 04:13 PM
Boughton Soleil	Officer	Nov 24 '25	Proposed Sale	35.11	2,631	92,374		Nov 24 10:03 AM
Okupe Oluyemi	Chief Financial Officer	Nov 17 '25	Option Exercise	7.15	23,187	165,817	93,419	Nov 19 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Nov 17 '25	Sale	36.81	23,187	853,490	70,232	Nov 19 04:31 PM
Boughton Soleil	Chief Legal Officer	Nov 10 '25	Sale	42.53	2,637	112,152	155,856	Nov 12 08:02 PM
Boughton Soleil	Officer	Nov 10 '25	Proposed Sale	42.53	2,637	112,152		Nov 10 10:16 AM
Boughton Soleil	Chief Legal Officer	Oct 27 '25	Sale	50.10	2,637	132,114	158,493	Oct 28 04:23 PM
Boughton Soleil	Officer	Oct 27 '25	Proposed Sale	50.10	2,637	132,114		Oct 27 09:42 AM

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Co-FounderMr. Andrew Dudum

Chief Operating OfficerMr. Mike Chi

Chief Technology OfficerMr. Mohamed ElShenawy

Chief Legal Officer & Corporate SecretaryMs. Soleil Teubner Boughton J.D.

Global Chief Medical OfficerDr. Patrick Carroll M.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HIMS

Hims & Hers Health Inc

Upgrade your Finviz experience